Science Pool

Date: March 12-14

Location: San Diego, CA

Attending:

Martha Zambrano, Senior Director Business Development at Just-Evotec Biologics

Magnus Schroeder, Vice President Process & Product Design at Just - Evotec Biologics

Presentation title: Achieving Fully Continuous Downstream

Speaker: Magnus Schroeder, Vice President Process & Product Design at Just - Evotec Biologics

Where: Recovery & Purification track

When: Thursday, 14 March at 11:00 – 11:30 am

Join us in-person in San Diego, CA, and secure your pass now. 

Book Now

Date: March 18-20

Location: Barcelona, Spain

Attending

• Jason Brown, SVP Business Development
• Florence Eustache, VP Business Development
• Nigel Shipston, Senior Director Business Development
  
  

Learn more about Bio-Europe Spring

Date: April 10 - 11

Location: San Francisco, CA, USA

Attending

• Philip Boehme, EVP Partnering and Transformation at Just-Evotec Biologics
• Jon Gunther, VP Business Development
• Martha Zambrano, Senior Director Business Development
• Eric Eith, Senior Director Business Development
  
  

Use the link below to request a meeting.

Contact Us to Arrange a Meeting

Presenting

Title: “THE SHIP HAS LANDED – CONTINUOUS MANUFACTURING: A PARADIGM SHIFT IN BIOLOGICS”

Presenter: Philip Boehme, EVP Partnering and Transformation at Just-Evotec Biologics

Date and Time: Day 2, 12:25 pm

Insights: 

• Pioneering a 10x leap in biomanufacturing, our approach stands out amidst incremental innovations in the industry
• Anchored by a highly diversified tech stack, our continuous manufacturing platform, including commercial GMP facilities, leads the way
• Revolutionizing antibody development through our proprietary AI/ML-based mAb discovery platform, we accelerate the journey from lab to clinic
• Validation from a prestigious client base, including recent collaborations with Sandoz and the Department of Defense, underscores the credibility of our approach.
• Positioned as a trailblazer between equipment manufacturers and Contract Development and Manufacturing Organizations (CDMOs), we are poised to redefine industry dynamics
  
  

Learn more about American Biomanufacturing Summit

Date:  March 18 - 21

Location: New York City, NY, USA

Evotec and Just - Evotec Biologics will be at DCAT Week 2024 - You can meet with our teams at the 48 LEX, meeting rooms 2104 for Evotec and 2004 for Just - Evotec Biologics.

Use the link below to request a meeting.

Contact Us to Arrange a Meeting

Attending

• Nicholas Johnson, SVP Business Development, Evotec
• Josh Gillum, VP Business Development, Evotec
• Philip Boehme, EVP, Head of Partnering and Transformation, Just - Evotec Biologics
• Todd Ireland, Senior Director Business Development, Just - Evotec Biologics
• Nick Hutchinson, Head of Market Development at Just-Evotec Biologics

Presentation title: Opening of Just-Evotec Biologics’ biomanufacturing facility J.POD Toulouse

Presenter: Nick Hutchinson, Head of Market Development at Just-Evotec Biologics

Where: Intercontinental Barclay Hotel 

When: 18th March, 10:00 am

Date:  February 28 - 29

Location: Dublin, Ireland

Attending

• Nigel Shipston, Senior Director Business Development Biologics at Just-Evotec Biologics

Learn more about Ireland Biomanufacturing Summit 2024

Date:  November 14 - 16

Location: San Diego, CA

Our team at PEGS Lisbon

• Matthias Evers, Chief Business Officer at Evotec
• Linda Zuckerman, EVP Global Head of Biotherapeutics at Just – Evotec Biologics
• Philip Boehme, EVP Partnering & Transformation at Evotec
• Ben Castro, SVP Manufacturing Operations at Just – Evotec Biologics
• Magnus Schroeder, VP Process & Product Design at Just – Evotec Biologics
• Jon Gunther, VP Business Development Biologics at Just – Evotec Biologics
• Todd Ireland, Senior Director Business Development Biologics at Just – Evotec Biologics
• Eric Eith, Senior Director Business Development Biologics at Just – Evotec Biologics

Presentation

Reduced COGM Through Continuous Manufacturing: Flexible J.POD® Platform

Presented by: Ben Castro, SVP Manufacturing Operations at Just – Evotec Biologics

Learn more about BMWS 2023

Date:  December 11 - 12

Location: Hybrid | Barcelona, Spain

Virtual Presentation

Applying Pharma 4.0 to Expand Access to Biotherapeutics

Track 4: Production 4.0 – Digital Supply Chain & Manufacturing Operations, Tuesday, December 12 at 10:30 - 11:00 am

Presented by: Charlie Maher Site Head & VP Manufacturing at Just – Evotec Biologics 

Learn more about ISPE Pharma 4.0

Date:  November 14 - 16

Location: Lisbon, Portugal

Our team at PEGS Lisbon

• Thierry Wurch, SVP Integrated Biologics Discovery and Development, Head of Antibody discovery, Evotec (France) SAS
• Leonie Enderle, Senior Research Scientist In Vitro Biology at Evotec
• James Hallinan, Senior Director Business Development at Evotec
• Nigel Shipston, Senior Director Business Development Biologics at Just-Evotec Biologics

Presentation

Evotec’s integrated Biologics continuum to strengthen immunotherapy discovery programs

Antibody-based Therapies track, Tuesday, November 14 at 3:40 pm

Presented by: Thierry Wurch, SVP Integrated Biologics Discovery and Development, Head of Antibody discovery, Evotec (France) SAS

Learn more about PEGS Lisbon

Date: 27 - 28 March 2023

Location: Cambridge, UK

Attending: Dr Anna Carbone and Dr Luca Raveglia 

Join us in-person in Cambridge for the 7th RSC/SCI Symposium on Ion Channels as Therapeutic Targets where Evotec will be presenting it's science.

Dr Anna Carbone from EPhys team in Hamburg will be speaking about EVOchannel safety platform.

Dr Luca Raveglia from Medicinal Chemistry in Verona will be presenting on TRPM5 project.

Learn more about the Symposium on Ion Channels as Therapeutic Targets  

Date: 24 - 25 April 2023

Location: Cambridge, MA

Attending: Matthias Austen and Christine Guenther 

Join us in-person in Cambridge for the 4th IPITA/HSCI/JDRF Summit on Stem Cell Derived Beta Cells where Evotec will be sponsoring and presenting it's science in collaboration with Sernova.

Presentation | April 24 from 2:45 - 4:25om ET
Manufacturing of optimized human islet-like clusters (ILCs) from iPSCs and functional testing of an ILC + Cell Pouch™ combination in vivo

Evotec has developed a scalable and comprehensive process for GMP manufacturing of ILCs from a human GMP-grade induced pluripotent stem cell (iPSC) line for cell therapy in human insulin-dependent diabetes. In 2022, Evotec entered into a collaboration with Sernova Corp., which has developed the proprietary Cell Pouch System™. Following implantation, the Cell Pouch develops a vascularized environment to support engraftment and long-term function of therapeutic cells. 

Authors: Audrey Holtzinger, Simone Strauch, Thomas Reinbothe, Claudia Wrzos, Andreas Scheel, Cord Dohrmann, Arash Memarnejadian, Pardis Pakshir, Philip M. Toleikis, Matthias Austen

Sernova will disclose additional information about the presentation at the time of the conference.

Learn more about the Summit on Stem Cell Derived Beta Cells